Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors by F. Illouz et al.
Endocrine side-effects of anti-cancer drugs: thyroid effects
of tyrosine kinase inhibitors
Submitted by Emmanuel Lemoine on Tue, 02/24/2015 - 15:28
Titre Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinaseinhibitors
Type de
publication Article de revue
Auteur Illouz, Frédéric [1], Braun, D. [2], Briet, C. [3], Schweizer, U. [4], Rodien, Patrice[5]
Editeur BioScientifica





Pagination R91 - 9
Volume 171
Titre de la revue European Journal of Endocrinology
ISSN 1479-683X
Mots-clés
Animals [6], Antineoplastic Agents/adverse effects [7], Endocrine System/drug
effects/metabolism [8], Humans [9], Protein Kinase Inhibitors/adverse effects [10],
Thyroid Diseases/chemically induced/metabolism [11], Thyroid Function




Tyrosine kinase inhibitors (TKIs) are currently used by most oncologists. Among
their side effects, thyroid dysfunctions are nowadays clearly observed. Whereas
changes in thyroid function tests have been originally described with sunitinib, we
now know that many TKIs can induce hypothyroidism and hyperthyroidism. In this
study, the various molecules implicated in thyroid dysfunctions are analysed and
the latest data on physiopathological mechanisms are approached in order to
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